In July 2017, Salamatac Trading was established to engage in pharmaceutical distribution within the Qatari market.
Since Salamatac Trading entered the pharmaceutical distribution sector in the Qatari market, it has signed numerous exclusive agreements and successfully launched a variety of products over the three consecutive years from 2017 to 2019.

In late 2019, Salamatac Trading achieved a significant milestone by signing its first regional agreement, marking a pivotal moment in the company's journey within the pharmaceutical distribution sector, particularly in the Qatari market.
In 2020, despite the significant challenges posed by the COVID-19 pandemic, Salamatac Trading successfully expanded its operations into the Qatari market and Kuwait, enhancing its capabilities in pharmaceutical distribution.
In 2021, Salamatac Trading has succeeded in adding another success story to its record by expanding into the United Arab Emirates through the establishment of its sister company EXIMPHA, further enhancing its presence in the pharmaceutical distribution sector and strengthening its foothold in the Qatari market.
The current year 2022 represents more hard work to be done, a lot of success to grab, and hope to grow more, especially in the pharmaceutical distribution sector within the Qatari market, where companies like Salamatac Trading are poised for growth.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.